7 Publikationen
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2977978Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapyPUB | DOI | WoS | PubMed | Europe PMC
Goon, Peter, Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy. npj Vaccines 8 (1). , 2023 -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2968186Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytesPUB | PDF | DOI | WoS | PubMed | Europe PMC
Shao, Senyao, Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytes. BMC Cancer 23 (1). , 2023 -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2965718Head and neck cancer cells can differentiate and resemble their tissue of originPUB | DOI | WoS
Oppel, Felix, Head and neck cancer cells can differentiate and resemble their tissue of origin. Proceedings: AACR Annual Meeting 2022; April 8-13, 2022; New Orleans, LA 82 (12_Supplement). , 2022 -
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2967816P35 Spatial proteomics and metabolomics investigations in head & neck cancersPUB | DOI | WoS
Gendreizig, Sarah, P35 Spatial proteomics and metabolomics investigations in head & neck cancers. Oral Oncology 134 (). , 2022 -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2967817P28 Head and neck cancer cells differentiate resembling their tissue of originPUB | DOI | WoS
Oppel, Felix, P28 Head and neck cancer cells differentiate resembling their tissue of origin. Abstracts of the 4th International Symposium on HPV Infection in Head and Neck Cancer Latest Advances in Biomarker-driven Management 134 (Suppl.). , 2022 -
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2965703p53 pathway inactivation drives SMARCB1-deficient p53-wildtype epithelioid sarcoma onset indicating therapeutic vulnerability through MDM2 inhibitionPUB | DOI | WoS | PubMed | Europe PMC
Oppel, Felix, p53 pathway inactivation drives SMARCB1-deficient p53-wildtype epithelioid sarcoma onset indicating therapeutic vulnerability through MDM2 inhibition. Molecular Cancer Therapeutics (). , 2022 -
2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2951607The Potential of Tumor Debulking to Support Molecular Targeted TherapiesPUB | DOI | WoS | PubMed | Europe PMC
Oppel, Felix, The Potential of Tumor Debulking to Support Molecular Targeted Therapies. Frontiers in Oncology 10 (). , 2020